1 | LC-MS-MS development and validation for simultaneous quantitation of metformin, glimepiride and pioglitazone in human plasma and its application to a bioequivalence study | 1100 |
2 | LC-MS/MS simulatneous determination of itopride hydrochloride and domperidone in human plasma | 1006 |
3 | Rapid and sensitive LC method for the analysis of Gemifloxacin in Human plasma | 961 |
4 | Development and validation of a high-performance liquid chromatographic method for bioanalytical application with rimonabant | 959 |
5 | Development and in vitro evaluation of micronized sustained release matrix tablet of carvedilol | 913 |
6 | Incorporation of carbopol to palm olein based analgesic cream: effect on formulation characteristics | 755 |
7 | Effects of mixing ibuprofen with hydrophobic and hydrophilic colloidal silicon dioxide on powder flow property and solubility: a comparative study | 696 |
8 | Polymeric behavior evaluation of PVP K30- poloxamer binary carrier for solid dispersed nisoldipine by experimental design | 681 |
9 | Polymer selection for nisoldipine solid dispersion to enhance solubility | 632 |
10 | Exploring blend uniformity of a binary mixture containing metformin Hcl and hydroxypropyl methyl cellulose by DSC | 619 |
11 | Advanced characterizations of nanoparticles for drug delivery: Investigating their existence through the techniques used in their evaluations | 607 |
12 | Glidant effect of hydrophobic and hydrophilic nanosilica on a cohesivepowder: comparison of different flow characterization techniques | 604 |
13 | Controversies with self-emulsifying drug delivery
system from pharmacokinetic point of view | 572 |
14 | Fast and simple gas chromatographic method for simultaneous
estimation of camphor, menthol and methyl salicylate in analgesic
ointment: application in stability study | 567 |
15 | Stability-indicating RP-HPLC method for simultaneous quantitation of tramadol and aceclofenac in presence of their major degradation products: Method development and validation | 563 |
16 | Mucoadhesive polymers and their mode of action: a recent update | 560 |
17 | Manufacturing operations | 548 |
18 | Micronized carvedilol SR matrix tablet for improved dissolution | 505 |
19 | Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs | 496 |
20 | Nose to brain drug delivery: a recent update | 496 |
21 | Improved dissolution, flow property and compressibility of poor soluble API by co-grinding with fine silica | 493 |
22 | Development of a binary carrier system consisting
polyethylene glycol 4000 - ethyl cellulose for ibuprofen solid dispersion | 490 |
23 | Non-gelatin or vegetative sourced capsule: miles crossed and miles to go | 474 |
24 | Assessment of preclinical pharmacokinetics and acute toxicity of pioglitazone and telmisartan combination | 393 |
25 | Pharmacokinetic and pharmacodynamic features of nanoemulsion following oral, intravenous, topical and nasal route | 386 |
26 | Transdermal delivery of raloxifene HCl via ethosomal system: Formulation, advanced characterizations and pharmacokinetic evaluation | 303 |
27 | Current regulatory requirements and practical approaches for stability analysis of pharmaceutical products: a comprehensive review | 301 |
28 | Formulation of dispersed gliclazide powder in polyethylene glycol–polyvinyl caprolactam– polyvinyl acetate grafted copolymer carrier for capsulation and improved dissolution | 221 |
29 | Formulation and in vitro characterization of raloxifene nanoemulgel for improved skin permeation | 200 |
30 | pH responsive polymers in drug delivery | 175 |